Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gynecologic 1

Conditions

Carcinoma, Non-Small-Cell Lung 62Rectal Neoplasms 49Breast Neoplasms 48Stomach Neoplasms 37Esophageal Neoplasms 36Colorectal Neoplasms 33Lung Neoplasms 30Squamous Cell Carcinoma of Head and Neck 28Pancreatic Neoplasms 25Brain Neoplasms 25Glioblastoma 23Neoplasms 22Sarcoma 21Neoplasm Metastasis 20Carcinoma, Hepatocellular 18Head and Neck Neoplasms 17Glioma 16Esophageal Squamous Cell Carcinoma 16Colonic Neoplasms 13Recurrence 11Ovarian Neoplasms 10Oropharyngeal Neoplasms 10Melanoma 10Astrocytoma 10Adenocarcinoma Of Esophagus 10Thyroid Neoplasms 9Hypopharyngeal Neoplasms 9Prostatic Neoplasms 8Laryngeal Neoplasms 8Central Nervous System Neoplasms 8

Interventions

camrelizumab 1Surgical Procedures, Operative 1Paclitaxel 1Carboplatin 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
OTHER × Endometrioid Endometrial Cancer × Surgical Procedures, Operative × Clear all
NCT06561308 2025-12-01

Clinical Efficacy Study of PD-1 Inhibitor Combined With Neoadjuvant Chemotherapy in Advanced Endometrial Cancer

Women's Hospital School Of Medicine Zhejiang University

Phase 2 Recruiting
39 enrolled
Gynecologic

Endometrioid Endometrial Cancer

Data powered by HemOnc (CC BY 4.0) Colophon âš¡